How have NDRA shares performed in 2024?

ENDRA Life Sciences' stock was trading at $2.12 on January 1st, 2024. Since then, NDRA stock has decreased by 89.0% and is now trading at $0.2334. View the best growth stocks for 2024 here .

Are investors shorting ENDRA Life Sciences?

ENDRA Life Sciences saw a decrease in short interest in March. As of March 31st, there was short interest totaling 30,600 shares, a decrease of 36.9% from the March 15th total of 48,500 shares. Based on an average daily volume of 170,700 shares, the short-interest ratio is presently 0.2 days. Approximately 0.3% of the shares of the stock are sold short. View ENDRA Life Sciences' Short Interest .

When is ENDRA Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NDRA earnings forecast .

How were ENDRA Life Sciences' earnings last quarter?

ENDRA Life Sciences Inc. (NASDAQ:NDRA) issued its earnings results on Monday, November, 15th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. During the same period last year, the company earned ($0.15) EPS.

What other stocks do shareholders of ENDRA Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD) , Trevena (TRVN) , VBI Vaccines (VBIV) , Bionano Genomics (BNGO) , OPKO Health (OPK) , TherapeuticsMD (TXMD) , electroCore (ECOR) and Genocea Biosciences (GNCA) .

When did ENDRA Life Sciences IPO?

ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO.

How do I buy shares of ENDRA Life Sciences?

Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NDRA

ENDRA Life Sciences (NDRA) Stock Price, News & Analysis

→ A new way to collect income from stocks (From DTI) (Ad)

Free NDRA Stock Alerts

$0.23

+0.00 (+1.13%)

(As of 04:35 PM ET)

Compare

Today's Range: $0.23
▼
$0.25
50-Day Range: $0.23
▼
$1.21
52-Week Range: $0.22
▼
$2.79

Volume: 57,956 shs
Average Volume: 171,075 shs
Market Capitalization: $2.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get ENDRA Life Sciences alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About ENDRA Life Sciences Stock (NASDAQ:NDRA)

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

NDRA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NDRA Stock News Headlines

April 12, 2024 | markets.businessinsider.com

IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus

April 1, 2024 | finance.yahoo.com

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 29, 2024 | finance.yahoo.com

Q4 2023 ENDRA Life Sciences Inc Earnings Call

March 28, 2024 | businesswire.com

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 27, 2024 | benzinga.com

Earnings Preview For ENDRA Life Sciences

March 21, 2024 | finance.yahoo.com

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

March 14, 2024 | msn.com

Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 6, 2024 | bizjournals.com

Life sciences companies need more than just scientists

February 28, 2024 | msn.com

ENDRA installs first TAEUS liver system at London hospital

February 27, 2024 | finance.yahoo.com

ENDRA Life Sciences Installs First TAEUS System in the UK

February 27, 2024 | businesswire.com

ENDRA Life Sciences Installs First TAEUS System in the UK

February 23, 2024 | msn.com

New findings suggest life span can be increased by making cells less efficient at producing energy

February 21, 2024 | finance.yahoo.com

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System

February 21, 2024 | businesswire.com

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

February 21, 2024 | investing.com

ENDRA Life Sciences Inc (NDRA)

February 17, 2024 | investing.com

ENDRA Life Sciences secures new patents for ultrasound tech

February 15, 2024 | wsj.com

ENDRA Life Sciences Inc.

February 14, 2024 | businesswire.com

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

February 9, 2024 | msn.com

Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15

February 6, 2024 | msn.com

Panacea Life Sciences Strikes, Rescinds PUR Medical Deal

February 4, 2024 | markets.businessinsider.com

Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant

December 10, 2023 | benzinga.com

ENDRA Life Sciences Stock (NASDAQ:NDRA) Dividends: History, Yield and Dates

November 29, 2023 | finance.yahoo.com

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

November 16, 2023 | msn.com

$116 Million Life Sciences, Health Care, and Tech Innovation Hub Coming to Jersey City

November 15, 2023 | msn.com

Dallas-based company plans to resurrect prehistoric life

See More Headlines

Receive NDRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:NDRA
CUSIP: N/A
CIK: 1681682
Web: www.endrainc.com
Phone: (734) 335-0468
Fax: N/A
Employees: 21
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.93)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,060,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -197.36%
Return on Assets: -144.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.26
Quick Ratio: 3.36

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.67 per share
Price / Book: 0.36

Miscellaneous

Outstanding Shares: 11,040,000
Free Float: 10,506,000
Market Cap: $2.66 million
Optionable: Not Optionable
Beta: 0.98

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Francois Michelon (Age 58)
Chairman, President & CEO
Comp: $423.59k
Mr. Michael Thornton Ph.D. (Age 56)
Chief Technology Officer
Comp: $301.67k
Dr. Jonathan Behr Ph.D.
Co-Founder
Ms. Irina Pestrikova (Age 37)
Senior Director of Finance & Secretary
Mr. Steve Freeman
Human Resources Leader

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

NDRA Stock Analysis - Frequently Asked Questions

How have NDRA shares performed in 2024?: ENDRA Life Sciences' stock was trading at $2.12 on January 1st, 2024. Since then, NDRA stock has decreased by 89.0% and is now trading at $0.2334.
View the best growth stocks for 2024 here.
Are investors shorting ENDRA Life Sciences?: ENDRA Life Sciences saw a decrease in short interest in March. As of March 31st, there was short interest totaling 30,600 shares, a decrease of 36.9% from the March 15th total of 48,500 shares. Based on an average daily volume of 170,700 shares, the short-interest ratio is presently 0.2 days. Approximately 0.3% of the shares of the stock are sold short.
View ENDRA Life Sciences' Short Interest.
When is ENDRA Life Sciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NDRA earnings forecast.
How were ENDRA Life Sciences' earnings last quarter?: ENDRA Life Sciences Inc. (NASDAQ:NDRA) issued its earnings results on Monday, November, 15th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. During the same period last year, the company earned ($0.15) EPS.

What other stocks do shareholders of ENDRA Life Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), electroCore (ECOR) and Genocea Biosciences (GNCA).
When did ENDRA Life Sciences IPO?: ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO.
How do I buy shares of ENDRA Life Sciences?: Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NDRA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial